MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,765.36
-0.47%
NASDAQ 100
$30,725.81
-1.39%
DOW JONES
$51,232.00
+0.10%
NASDAQ Composite
$27,193.34
-1.25%
RUSSELL 2000
$2,775.70
-0.05%
CBOE VIX
$15.41
+2.19%
Sector Heatmap
Technology-1.79%
Financials+0.89%
Healthcare-0.39%
Consumer Cycl+0.31%
Consumer Staples+2.11%
Energy+2.97%
Industrials+0.33%
Materials+0.59%
Real Estate+0.69%
Utilities-0.19%
Comm Services+0.73%
SRZN — Surrozen, Inc. Common
NasdaqSurrozen, Inc. Common
$27.97
+2.83(+11.23%)
- O
- 25.00
- H
- 28.85
- L
- 23.54
- V
- 680.97K
⏱️ End-of-day dataAs of Oct 8, 2026
Chart
About SRZN
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
SectorNot available
IPO DateAug 12, 2021
Employees44
Stock ExchangeNasdaq
Ticker SymbolSRZN
Websitehttps://www.surrozen.com
Key Financial Statistics
| Market Cap | $344.61M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $11.39 - $37.83 |
| 52-Week Avg Volume | 203.9K |
| VWAP | $26.96 |
| Transactions | 7,161 |
| Total Recorded Bars | 1,443 days |